ENDRA Life Sciences Inc.
NDRA- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001681682
No open-market purchases or sales by ENDRA Life Sciences Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $819.0K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in ENDRA Life Sciences Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −2 vs. Q1 2023
- Shares held
- 190.5K
- +22.2K (+13.2%) vs. Q1 2023
- Total value
- $267.5K
- −$117.2K (−30.5%) vs. Q1 2023
- New holders
- 4
- 4 more added
- Sold out
- 6
- 3 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NDRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $819.0K |
| Q1 2026 | 8 | $416.8K |
| Q4 2025 | 7 | $325.4K |
| Q3 2025 | 5 | $70.4K |
| Q2 2025 | 3 | $16.6K |
| Q1 2025 | 2 | $4.65K |
| Q4 2024 | 4 | $720 |
| Q3 2024 | 11 | $32.9K |
| Q2 2024 | 17 | $80.6K |
| Q1 2024 | 13 | $153.0K |
| Q4 2023 | 11 | $277.3K |
| Q3 2023 | 10 | $156.3K |
| Q2 2023 | 12 | $267.5K |
| Q1 2023 | 14 | $384.7K |
| Q4 2022 | 14 | $569.5K |
| Q3 2022 | 16 | $1.08M |
| Q2 2022 | 20 | $1.02M |
| Q1 2022 | 20 | $1.54M |
| Q4 2021 | 20 | $3.06M |
| Q3 2021 | 20 | $6.06M |
| Q2 2021 | 23 | $7.75M |
| Q1 2021 | 22 | $8.35M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding ENDRA Life Sciences Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 58,054 | $82.4K | 0.00% | +39,142+207.0% | Added |
| Citadel Advisors LLC | 36,701 | $52.1K | 0.00% | +36,701 | New |
| GWM Advisors LLC | 32,260 | $45.2K | 0.00% | −309−0.9% | Reduced |
| Vanguard Group Inc | 26,551 | $37.2K | 0.00% | −23,332−46.8% | Reduced |
| Two Sigma Securities, LLC | 11,343 | $15.9K | 0.00% | +11,343 | New |
| Renaissance Technologies LLC | 10,994 | $15.0K | 0.00% | +10,994 | New |
| HRT Financial LP | 10,495 | $14.0K | 0.00% | +10,495 | New |
| Tower Research Capital LLC (TRC) | 2,493 | $3.49K | 0.00% | +2,398+2,524.2% | Added |
| Morgan Stanley | 781 | $1.09K | 0.00% | −24,959−97.0% | Reduced |
| Worth Asset Management, LLC | 670 | $938 | 0.00% | +400+148.1% | Added |
| BlackRock Inc. | 103 | $144 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 50 | $70 | 0.00% | +28+127.3% | Added |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −15,542−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,641−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −6,943−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −4,515−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −766−100.0% | Sold out |
| Cranbrook Wealth Management, LLC | 0 | $0 | 0.00% | −272−100.0% | Sold out |